LuAnn Via Net Worth

The estimated Net Worth of Lu Ann Via is at least $114 mil dollars as of 21 November 2019. Ms. Via owns over 5,000 units of STRATA Skin Sciences Inc stock worth over $113,646 and over the last 8 years she sold SSKN stock worth over $0. In addition, she makes $0 as Chairman of the Board at STRATA Skin Sciences Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms. Via SSKN stock SEC Form 4 insiders trading

LuAnn has made over 4 trades of the STRATA Skin Sciences Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently she bought 5,000 units of SSKN stock worth $12,500 on 21 November 2019.

The largest trade she's ever made was buying 25,000 units of STRATA Skin Sciences Inc stock on 8 June 2018 worth over $53,500. On average, LuAnn trades about 4,444 units every 59 days since 2016. As of 21 November 2019 she still owns at least 35,570 units of STRATA Skin Sciences Inc stock.

You can see the complete history of Ms. Via stock trades at the bottom of the page.

LuAnn Via biography

LuAnn Via is Chairman of the Board of the Company. She has served as President and Chief Executive Officer, and a member of the Board of Directors, of Christopher & Banks Corporation, a specialty retailer of women's clothes; a company operating more than 500 retail stores. Prior to this, Ms. Via served as the President and Chief Executive Officer of Payless ShoeSource, a unit of Collective Brands, Inc., from July 2008 to October 2012 when the company was acquired and taken private. Before joining Payless ShoeSource, from January 2006 Ms. Via served as group divisional President of Lane Bryant and Cacique store chains and as President of Catherines stores, both divisions of Charming Shoppes, Inc. Prior to this, and for more than 20 years, Ms. Via held several leadership positions with a number of top retailers. Ms. Via also serves on the Committee of 200 Governing Board and the ALSAC/St. Jude Professional Advisory Board. The Company believes Ms. Via's qualifications to serve on the Board of Directors include her extensive experience as a senior executive of a publicly-listed company and experience in retail sales.

How old is LuAnn Via?

LuAnn Via is 62, she's been the Chairman of the Board of STRATA Skin Sciences Inc since 2017. There are 5 older and 5 younger executives at STRATA Skin Sciences Inc. The oldest executive at STRATA Skin Sciences Inc is Dr. Darrell S. Rigel, 70, who is the Chief Medical Advisor.

What's LuAnn Via's mailing address?

Lu's mailing address filed with the SEC is C/O STRATA SKIN SCIENCES, INC., 5 WALNUT GROVE DRIVE, HORSHAM, PA, 19044.

Insiders trading at STRATA Skin Sciences Inc

Over the last 9 years, insiders at STRATA Skin Sciences Inc have traded over $348,780 worth of STRATA Skin Sciences Inc stock and bought 2,664,087 units worth $2,970,754 . The most active insiders traders include Healthcare Master Fund Ltd ..., Lp22 Nw Fund, Lp22 Nw Fund ... y Dolev Rafaeli. On average, STRATA Skin Sciences Inc executives and independent directors trade stock every 127 days with the average trade being worth of $392,199. The most recent stock trade was executed by Uri Geiger on 15 July 2024, trading 230,573 units of SSKN stock currently worth $723,999.

What does STRATA Skin Sciences Inc do?

formerly mela sciences, strata skin sciences is a new company built by unconventional thinkers. a medical technology company that brings hope and help to the dermatology patient in all of us. it’s not just a device or a technology, it’s optimism for psoriasis, determination for improving patients’ lives, and advocacy for getting it right.

Complete history of Ms. Via stock trades at STRATA Skin Sciences Inc

STRATA Skin Sciences Inc executives and stock owners

STRATA Skin Sciences Inc executives and other stock owners filed with the SEC include:

• Michael R. Stewart,
  Independent Consultant
• Kathryn Swintek,
  Independent Director
• David Stone,
  Independent Director
• Samuel Navarro,
  Independent Director
• Jeffrey O'Donnell,
  Director
• James Coyne,
  Director
• Matthew Hill,
  Chief Financial Officer
• Dolev Rafaeli,
  Interim Chief Executive Officer
• Frank McCaney,
  President, Director
• LuAnn Via,
  Chairman of the Board
• Nikolai Kabelev,
  VP of R&D
• Shmuel Gov,
  Exec. VP & GM
• Dr. Darrell S. Rigel,
  Chief Medical Advisor
• Keith Simeone,
  VP of Sales
• Jay Sturm,
  Gen. Counsel & Corp. Sec.
• Christopher Lesovitz,
  Chief Financial Officer
• Robert J. Moccia,
  Pres, CEO & Director
• William D. Humphries,
  Exec. Chairman
• Healthcare Master Fund Ltd ...,
  
• Michael R Stewart,
  President & CEO
• Richard Rox Anderson,
  Director
• Christina L Allgeier,
  CFO
• David N Gill,
  
• Partners, L.P.Accelmed Part...,
  
• Douglas Strang,
  
• Samuel Rubinstein,
  
• Nachum Shamir,
  
• Christopher Lesovitz,
  Chief Financial Officer
• William D. Humphries,
  
• Uri Geiger,
  Director
• Wayne Cafran,
  
• Irit Yaniv,
  
• Patricia S Walker,
  
• Robert Joseph Moccia,
  Chief Executive Officer
• Lp22 Nw Fund, Lp22 Nw Fund ...,
  
• Shmuel Gov,
  COO